CTOs on the Move

General Electric Healthcare

www.gehealthcare.com

 
GE Healthcare provides transformational medical technologies and services that are shaping a new age of patient care. Our broad expertise in medical imaging and information technologies, medical diagnostics, patient monitoring systems, drug discovery, biopharmaceutical manufacturing technologies, performance improvement and performance solutions services help our customers to deliver better care to more people around the world at a lower cost. In addition, we partner with healthcare leaders, striving to leverage the global policy change necessary to implement a successful shift to sustainable healthcare systems. Our "healthymagination" vision for the future invites the world to join us on our journey as we continuously develop ...
  • Number of Employees: 10K-50K
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details
Rahel Ephrem
 VP of Software Engineering Profile
Glenn Korhorn
 Vice President of Quality for Advanced Visualization Solutions at GE HealthCare Profile
Jill Cornell
 VP, Quality, MR Profile
Martin Brown
 Director- GE HealthCare Technology and Profile
Taha Kass-Hout
 Chief Technology Officer Profile

Similar Companies

Quincy Lab

Quincy Lab is a Chicago, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Diasys Corp

Diasys Corp is a Waterbury, CT-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

emed

emed is a Thousand Oaks, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Intermountain Medical Solutions

Intermountain Medical Solutions is a Heber City, UT-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Glaukos

Glaukos Corporation is an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures to transform the treatment of glaucoma, one of the world`s leading causes of blindness. Glaukos has pioneered Micro-Invasive Glaucoma Surgery, or MIGS, to revolutionize the traditional glaucoma treatment and management paradigm. The company launched the iStent Trabecular Micro-Bypass Stent, its first MIGS device, in the United States in 2012. Glaukos is leveraging its platform technology to build a comprehensive and proprietary portfolio of injectable micro-scale therapies designed to address the complete range of glaucoma disease states and progression. Glaukos believes the iStent is the smallest medical device ever approved by the Food and Drug Administration, or FDA, measuring 1.0 mm long and 0.33 mm wide. In June 2015, the company completed an initial public offering and its shares are now traded on the New York Stock Exchange under the ticker symbol "GKOS". Founded in 1998, Glaukos is based in San Clemente, California.